RGLS
Charles Schwab’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-178,879
| Closed | -$313K | – | 3564 |
|
|
2025
Q1 | $313K | Hold |
178,879
| – | – | ﹤0.01% | 3199 |
|
|
2024
Q4 | $283K | Hold |
178,879
| – | – | ﹤0.01% | 3281 |
|
|
2024
Q3 | $281K | Hold |
178,879
| – | – | ﹤0.01% | 3297 |
|
|
2024
Q2 | $319K | Buy |
+178,879
| New | +$319K | ﹤0.01% | 3353 |
|
|
2021
Q2 | – | Sell |
-26,759
| Closed | -$42K | – | 3519 |
|
|
2021
Q1 | $42K | Buy |
+26,759
| New | +$42K | ﹤0.01% | 3455 |
|
|
2017
Q2 | – | Sell |
-61,781
| Closed | -$102K | – | 3128 |
|
|
2017
Q1 | $102K | Hold |
61,781
| – | – | ﹤0.01% | 3016 |
|
|
2016
Q4 | $140K | Hold |
61,781
| – | – | ﹤0.01% | 3016 |
|
|
2016
Q3 | $204K | Hold |
61,781
| – | – | ﹤0.01% | 2914 |
|
|
2016
Q2 | $179K | Buy |
61,781
+22,100
| +56% | +$64K | ﹤0.01% | 2975 |
|
|
2016
Q1 | $275K | Hold |
39,681
| – | – | ﹤0.01% | 2802 |
|
|
2015
Q4 | $347K | Hold |
39,681
| – | – | ﹤0.01% | 2804 |
|
|
2015
Q3 | $260K | Hold |
39,681
| – | – | ﹤0.01% | 2879 |
|
|
2015
Q2 | $435K | Buy |
39,681
+16,381
| +70% | +$180K | ﹤0.01% | 2722 |
|
|
2015
Q1 | $395K | Buy |
23,300
+5,200
| +29% | +$88.2K | ﹤0.01% | 2719 |
|
|
2014
Q4 | $291K | Hold |
18,100
| – | – | ﹤0.01% | 2851 |
|
|
2014
Q3 | $124K | Hold |
18,100
| – | – | ﹤0.01% | 3026 |
|
|
2014
Q2 | $146K | Hold |
18,100
| – | – | ﹤0.01% | 3045 |
|
|
2014
Q1 | $164K | Hold |
18,100
| – | – | ﹤0.01% | 2990 |
|
|
2013
Q4 | $134K | Hold |
18,100
| – | – | ﹤0.01% | 3030 |
|
|
2013
Q3 | $168K | Hold |
18,100
| – | – | ﹤0.01% | 2962 |
|
|
2013
Q2 | $181K | Buy |
+18,100
| New | +$181K | ﹤0.01% | 2937 |
|